GlassScriptPhysician profile
Nicholas Garrett Vance
NPI 1760774616
$6,734.28
in general payments reported to CMS, 2019-2025
27 companies · $377 in 2025
The $377 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $186 · 2021: $3,014 · 2022: $259 · 2023: $333 · 2024: $2,308 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,542 · Food and Beverage: $1,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,541.66 |
| Food and Beverage | $1,476.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $3,412.50 | 2021-2024 | |
| Arthrex, INC. | $1,059.70 | 2024 | |
| Smith+Nephew, INC. | $590.84 | 2021-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $361.67 | 2019-2025 | Tfn-Advance, Motoband, Orthovisc |
| Pacira Therapeutics, INC. | $191.64 | 2019-2021 | |
| Onkos Surgical, INC. | $160.72 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $131.87 | 2022-2024 | Zilretta, Exparel, Iovera |
| Ferring Pharmaceuticals INC. | $131.68 | 2019-2021 | |
| Medical Device Business Services, INC. | $117.49 | 2021 | |
| Orthofix Medical, INC. | $63.39 | 2019-2023 | Physio-Stim, Spinal-Stim |
| Zimmer Biomet Holdings, INC. | $57.07 | 2024 | |
| Djo, LLC | $48.25 | 2024 | Cmf |
| Amgen INC. | $41.96 | 2022-2025 | Evenity |
| Stryker Corporation | $41.00 | 2024-2025 | System 9 Cd Nxt |
| Teleflex LLC | $40.92 | 2024-2025 | Urolift |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $37.14 | 2023-2024 | Aponvie, Zynrelef |
| Bioventus LLC | $36.83 | 2021 | |
| Radius Health, INC. | $34.69 | 2021-2023 | Tymlos |
| Heraeus Medical, LLC. | $34.39 | 2020-2022 | |
| Treace Medical Concepts, INC. | $24.45 | 2022 | |
| Boston Scientific Corporation | $23.33 | 2023 | Wavewriter Alpha Prime 16 |
| Acelrx Pharmaceuticals, INC. | $18.09 | 2021 | |
| Baudax Bio INC. | $17.06 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $16.05 | 2020 | |
| Avanos Medical | $14.58 | 2019 | |
| Paragon 28, INC. | $14.21 | 2019 | |
| Davol INC. | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Vance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.